Orforglipron
A Master Protocol for Orforglipron (LY3502970) in Participants With Hypertension and Obesity or Overweight: (ATTAIN-Hypertension Screening)
Eli Lilly · Phase 3 · Active, not recruiting · Enrollment 974
No selected arm has a reported week for this endpoint.
A solid line connects the weeks the source reports.